SIRT2 can bind to the Nuclear Factor of Activated T Cells 2(NFATc2) and deacetylate it, further repressing the occurrence of pathological cardiac hypertrophy [158]. This evidence concerns the gene NFATC2 and cardiac hypertrophy.